Related Experiment Videos
External ocular herpesvirus infections in immunodeficiency
1Department of Ophthalmology, Washington University School of Medicine, St. Louis, MO 63110.
Current Eye Research
|January 1, 1991
Summary
Eye infections caused by herpesviruses (like HSV, CMV, VZV) are common in people with weakened immunity. Immune system defects influence viral latency, reactivation, and replication within ocular tissues.
Area of Science:
- Ophthalmology
- Virology
- Immunology
Background:
- Herpesvirus infections, including herpes simplex virus (HSV), cytomegalovirus (CMV), and varicella-zoster virus (VZV), frequently affect the eye.
- These ocular infections are particularly prevalent in individuals with compromised cell-mediated immunity, whether acquired or inherited.
- In immunocompromised individuals, herpesvirus infections can result from viral reactivation or primary infection, leading to widespread ocular disease.
Purpose of the Study:
- To review experimental and clinical studies on ocular herpesvirus infections in the context of immune dysfunction.
- To elucidate the specific immune mechanisms involved in the establishment of viral latency.
- To understand immune system's role in controlling viral reactivation and replication in ocular tissues.
Main Methods:
- Review of existing experimental and clinical literature.
- Analysis of studies focusing on acquired and inherited immune dysfunction.
- Examination of immune system's influence on herpesvirus lifecycle within the eye.
Main Results:
- Cell-mediated immunity plays a critical role in controlling ocular herpesvirus infections.
- Immune defects significantly impact the establishment of viral latency and subsequent reactivation.
- Specific immune mechanisms are implicated in regulating active viral replication in ocular structures.
Conclusions:
- Ocular herpesvirus infections are closely linked to the status of the host's immune system.
- Understanding immune mechanisms is crucial for managing latency, reactivation, and replication of ocular herpesviruses.
- Targeting immune pathways may offer therapeutic strategies for ocular herpesvirus infections.